Effect of topical capsaicin versus cryotherapy on clinical sign in patients with verruca vulgaris

Effect of topical capsaicin versus cryotherapy on clinical sign in patients with verruca vulgaris: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201601179014N89

Enrollment

108

Registered

2016-01-21

Start date

2015-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Verruca vulgaris. Viral warts

Interventions

Intervention 1: Topical capsaicin three a day for 6 weeks. Intervention 2: Cryotherapy every two weeks for 6 weeks.

Treatment - Drugs

Topical capsaicin three a day for 6 weeks

Cryotherapy every two weeks for 6 weeks

Eligibility

Sex/Gender

All

Age

5 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) age between 5 to 70 years; (b) having at least one wart with 5 mm diameter on the dorsum of the hand. Exclusion criteria: (a) immunodeficiency; (b) pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Diameter of wart. Timepoint: 6 weeks after beginning of treatment. Method of measurement: using vernier ruler.	—

Secondary

Measure	Time frame
Erythema. Timepoint: 6 weeks after beginning of treatment. Method of measurement: through question.;Local pain or burning. Timepoint: 6 weeks after beginning of treatment. Method of measurement: through question.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Khezrian

Farshchian Hospital

khezrian.leila@yahoo.com+98 81 3827 4184

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026